Advances in the medical treatment of Cushing's syndrome.
Feelders RA, Newell-Price J, Pivonello R, Nieman LK, Hofland LJ, Lacroix A.
Feelders RA, et al.
Lancet Diabetes Endocrinol. 2019 Apr;7(4):300-312. doi: 10.1016/S2213-8587(18)30155-4. Epub 2018 Jul 20.
Lancet Diabetes Endocrinol. 2019.
PMID: 30033041
Review.
Cushing's syndrome is associated with multisystem morbidity and, when suboptimally treated, increased mortality. ...CORT125134 is a new selective glucocorticoid receptor antagonist under investigation. We summarise the drug therapies for various forms of Cush …
Cushing's syndrome is associated with multisystem morbidity and, when suboptimally treated, increased mortality. ...CORT125134 …